1 / 14

MOOD DISORDERS

MOOD DISORDERS. YARD.DOÇ.DR. N. BERFU AKBAŞ YEDİTEPE ÜNİVERSİTESİ PSİKİYATRİ AD. 1-DEPRESSIVE DISORDERS. - MAJOR DEPRESSIVE DISORDER( MDD ) %10-25 women , %5-12 men Persistant depressive disorder 2- BIPOLAR DISORDERS. Neurobiological approaches to aetiology. Monoamine hypothesis:

emory
Download Presentation

MOOD DISORDERS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. MOOD DISORDERS YARD.DOÇ.DR. N. BERFU AKBAŞ YEDİTEPE ÜNİVERSİTESİ PSİKİYATRİ AD

  2. 1-DEPRESSIVE DISORDERS -MAJOR DEPRESSIVE DISORDER( MDD ) %10-25 women, %5-12 men • Persistantdepressivedisorder 2- BIPOLAR DISORDERS

  3. Neurobiological approaches to aetiology • Monoamine hypothesis: Serotonin, noradrenaline, dopamine, • Aminoacid neurotransmitters Glutamate (), GABA() • Endocrine abnormalities HPA axis

  4. DSM5 CRITERIA for DEPRESSION • For at least 2 weeks, at least 5 of thebelowsymptomsshould be present: • Depressedmood* • Decreasedinterestorpleasure in activities* • Change in apetite • Sleepchanges • Pscyhomotoragitationorretardation • Fatigueorloss of energy • Feelings of worthlessnessorguilt • Concentrationdifficulties • Thoughts of death

  5. ETIOLOGY • BiogenicAmines ( norepinephrine, serotonin, dopamine ) • NeuroendocrineRegulation Adrenal axis ( cortisolhypersecretion) Thyroidaxis ( hypotyroidism) Growthhormone ( sleepabnormalities) • Limbicsystem, basalgangliaandhypothalamusmostaffected • Geneticfactors • Psychosocialfactors ( stress, personality)

  6. SPECIFIERS DESCRIBING MOST RECENT EPISODE • Psychoticfeatures • Melancholicfeatures (endogeneousdepression) • Atypicalfeatures (overeating, oversleeping...) • Catotonicfeatures ( immobility, negativism, mutism) • Postpartumonset

  7. DYSTHYMIA • Depressedmoodfor at least 2 years + 2 of thefollowing; • Apetitechanges, sleepchanges, lowenergy, low self-esteem, poorconcentration, feelings of hopelessness. • “İllhumored”, mostcasesearlyonset • DOUBLE DEPRESSION: dysthymia + MDD

  8. TREATMENT • Pharmacotherapy: • Tricyclicantidepressants: İmipramine ( tofranil), clomipramine ( anafranil ), amitriptiline ( laroxyl ), ( sideeffects: hypotension, arrithmias, seizures ) • Serotoninreuptakeinhibitors: Fluoxetine ( prozac), citalopram ( cipram), sertraline ( Lustral ), paroxetine ( paxil), essitalopram ( cipralex ) ( sideeffects: GI disturbance, bleeding? Bruxism? ) • ECT

  9. BIPOLAR DISORDERS • BIPOLAR 1 DISORDER: • %0.4-1.6, equalprevelanceamongsexes. • Onset is earlierthandepression • 1 parentBipolar: %25 risk in thesibling • Dx: At least 1 manicepisodelastingfor 1 week • Mania: at least 3 of following: -Grandiosity - psychomotoragitation -Decreasedneedforsleep - excessiveactivities -Talking -Flight of ideas -distractibility

  10. ManicPatientsare: • Excited, talkative, sometimesamusing • Cannot be interruptedwhilespeaking, loud • Delusionsoccur in %75 ( grandiose ) • %75 assaultiveortreatening • Unreliable, lying

  11. BIPOLAR II DISORDER • Presence of oneormoredepressiveepisodes • Presence of at leastonehypomanicepisode • Hypomania:at least 4 days 3 of thefollowing; • Grandiosity • Decreasedneedforsleep • Talkative • Flight of ideas • Distractibility • Psychomotoragitation • Excessivepleasurableactivities

  12. TREATMENT • Depressiveattacks: antidepressants • Manicattacks: moodstabilizers+ antipsychotics + benzodiazepines • MoodStabilizers: • Lithium • Antiepileptics • Thesedrugsareusedchronically

  13. CYCLOTHYMIC DISORDER -Episodes of hypomaniaandmilddepressionfor 2 years. -%1 life time prevalance, 15-25 yearsonset • F/M=3/2 • ınstability in relationships • Changes in moodareirregular, abrupt • Commonsubstanceusedisorders • Tx: moodstabilizers • Antidepressantsswitchto mania

More Related